Dawn Morelli

500 total citations
9 papers, 381 citations indexed

About

Dawn Morelli is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Dawn Morelli has authored 9 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Dawn Morelli's work include Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Dawn Morelli is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Dawn Morelli collaborates with scholars based in United States, Switzerland and Brazil. Dawn Morelli's co-authors include Amod A. Sarnaik, Jeffrey S. Weber, Bin Yu, Daohai Yu, MacLean Hall, Michael Yellin, Lulu Yan, Geoff Nichol, Xiuhua Zhao and Wenshi Wang and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Dawn Morelli

9 papers receiving 374 citations

Peers

Dawn Morelli

ONCOL

IMMUN

MB

CP

ECP

Lijuan Qiu China

Takashi Miyagi Japan

Nicole Roberts United States

Tuba Öcek Baş Türkiye

Kotaro Yuge Japan

Tetsuo Tani Japan

Xufei Du China

Jeffrey Y.C. Chao Taiwan

Elizabeth Cameron United States

Lijuan Qiu China

Dawn Morelli

57 ×0.2

ONCOL

69 ×0.4

IMMUN

54 ×0.5

MB

34 ×0.6

CP

14 ×0.5

ECP

Citations per year, relative to Dawn Morelli Dawn Morelli (= 1×) peers Lijuan Qiu

Countries citing papers authored by Dawn Morelli

Since Specialization

Citations

This map shows the geographic impact of Dawn Morelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Morelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Morelli more than expected).

Fields of papers citing papers by Dawn Morelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn Morelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Morelli. The network helps show where Dawn Morelli may publish in the future.

Co-authorship network of co-authors of Dawn Morelli

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn Morelli. A scholar is included among the top collaborators of Dawn Morelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn Morelli. Dawn Morelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Morelli, Dawn, et al.. (2019). Use of Near-Infrared Spectroscopy to Monitor Lower Extremity Perfusion in Pediatric Patients Undergoing Cardiac Catheterization. Pediatric Cardiology. 40(7). 1523–1529. 1 indexed citations

2.

Wang, Wenshi, Daohai Yu, Amod A. Sarnaik, et al.. (2012). Biomarkers on melanoma patient T Cells associated with ipilimumab treatment. Journal of Translational Medicine. 10(1). 146–146. 86 indexed citations

3.

Diniz, Juliana Belo, Dante Marino Malavazzi, Carolina Valério, et al.. (2011). Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: A practical clinical trial. Journal of Anxiety Disorders. 26(1). 25–31. 58 indexed citations

4.

Weber, Jeffrey S., Bin Yu, MacLean Hall, et al.. (2011). Pharmacodynamic and predictive markers of ipilimumab on melanoma patients’ T-cells.. Journal of Clinical Oncology. 29(15_suppl). 2503–2503. 4 indexed citations

5.

Kiluk, John V., Paramjeet Kaur, Tammi Meade, et al.. (2010). Effects of Prior Augmentation and Reduction Mammoplasty to Sentinel Node Lymphatic Mapping in Breast Cancer. The Breast Journal. 16(6). 598–602. 7 indexed citations

6.

Damşa, Crina, et al.. (2010). Are Psychiatric Residents Still Interested in Psychoanalysis? A Brief Report. The American Journal of Psychoanalysis. 70(4). 386–391. 6 indexed citations

7.

Sarnaik, Amod A., Bin Yu, Daohai Yu, et al.. (2010). Extended Dose Ipilimumab with a Peptide Vaccine: Immune Correlates Associated with Clinical Benefit in Patients with Resected High-Risk Stage IIIc/IV Melanoma. Clinical Cancer Research. 17(4). 896–906. 157 indexed citations

8.

Marchion, Douglas C., Elona Biçaku, Joel G. Turner, et al.. (2009). HDAC2 regulates chromatin plasticity and enhances DNA vulnerability. Molecular Cancer Therapeutics. 8(4). 794–801. 54 indexed citations

9.

Weber, Jeffrey S., Amod A. Sarnaik, Ş. Targan, et al.. (2009). Phase II trial of extended dose anti-CTLA-4 antibody ipilimumab (formerly MDX-010) with a multipeptide vaccine for resected stages IIIC and IV melanoma. Journal of Clinical Oncology. 27(15_suppl). 9023–9023. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact